Trial Profile
Efficacy and safety of eribulin in patients with advanced breast cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Oct 2014
Price :
$35
*
At a glance
- Drugs Eribulin (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 08 Oct 2014 New trial record